Novocure Ltd (NVCR) — Capital Reinvestment Ratio
Latest as of September 2025:
0.27x
Novocure Ltd (NVCR) has a Capital Reinvestment Ratio of 0.27x as of September 2025, meaning it reinvests 0% of its operating cash flow ($20.57 Million) in capital expenditures ($5.66 Million). See how much free cash does Novocure Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.27x
Capex / Operating Cash Flow
Operating Cash Flow
$20.57 Million
USD
Capital Expenditures
$5.66 Million
USD
Data as of
Sep 2025
Most recent filing
Novocure Ltd Capital Reinvestment Ratio (2019–2022)
This chart tracks Novocure Ltd's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Novocure Ltd (2019–2022)
Year-by-year Capital Reinvestment Ratio for Novocure Ltd from 2019 to 2022. For live market cap and broader valuation context, see Novocure Ltd (NVCR) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.69x | $30.79 Million | $21.36 Million | ▲ +137.5% |
| 2021 | 0.29x | $82.76 Million | $24.17 Million | ▲ +93.5% |
| 2020 | 0.15x | $99.15 Million | $14.97 Million | ▼ -61.7% |
| 2019 | 0.39x | $26.62 Million | $10.48 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow